Evogene Ltd.
EVGN
$0.57
-$0.03-4.91%
NASDAQ
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -1,343.33% | 17.66% | 33.03% | 106.47% | 39.12% |
| Total Depreciation and Amortization | -40.36% | 383.33% | -53.80% | -33.48% | 2.48% |
| Total Amortization of Deferred Charges | 0.00% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 142.08% | 323.79% | -263.98% | -830.33% | 180.79% |
| Change in Net Operating Assets | 41.01% | 548.68% | 17.68% | -166.95% | -204.19% |
| Cash from Operations | 41.11% | 57.82% | -26.08% | 23.02% | 38.82% |
| Capital Expenditure | 98.14% | 92.00% | 14.18% | -274.42% | 4.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 12.58% | -130.51% | 45.07% | 1,916.00% | 1,801.48% |
| Cash from Investing | 17.18% | -130.81% | 43.95% | 1,594.54% | 16,663.64% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 57.10% | 42.68% | 36.80% | -46.23% | -- |
| Issuance of Common Stock | -- | 5,060.24% | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -218.27% | -40.00% | 90.65% | 420.00% | -100.58% |
| Cash from Financing | -24.27% | 2,847.68% | 56.68% | -40.14% | -23.30% |
| Foreign Exchange rate Adjustments | 228.57% | 228.57% | -11.11% | -107.07% | 71.13% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 83.99% | 134.31% | 11.87% | 160.74% | 137.15% |